Lv5
980 积分 2022-08-15 加入
Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy–Ineligible Patients With Isocitrate Dehydrogenase–Mutated AML
21小时前
待确认
Tumor microenvironment heterogeneity and progression mechanisms in intrahepatic cholangiocarcinoma: A study based on single-cell and spatial transcriptomic sequencing
5天前
已完结
Artificial intelligence in cardiovascular medicine: clinical applications
6天前
已完结
Anti-HER2 therapies in biliary tract cancers: A meta-analysis on disease location, HER2 status, and survival outcomes
12天前
已关闭
Generation of a biliary tract cancer cell line atlas identifies molecular subtypes and therapeutic targets
1个月前
已完结
Safety and Efficacy of Anti–Human Epidermal Growth Factor 2 Agents in the Treatment of Biliary Tract Cancers: A Systematic Review
1个月前
已关闭
Systemic therapy for pretreated advanced biliary tract cancer: past developments and recent advances
1个月前
已关闭
Immunotherapy
1个月前
已完结
Varicose vein is associated with an increased risk of ischemic stroke: a population-based matched cohort study
1个月前
已完结
Real-world efficacy of zanidatamab in patients with HER2 positive advanced biliary tract cancers
1个月前
已完结
胰腺癌诊疗指南(2022年版)
2年前
已采纳
皖公网安备34019202002308
